리툭시맙으로 효과적으로 치료한 스테로이드 비반응하시모토뇌병증
Steroid Non-responsive Hashimoto’s Encephalopathy Improved by Rituximab
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Hashimoto’s encephalopathy is a rare autoimmune disease, with symptoms of encephalopathy and high titers of serum anti-thyroid antibodies. Current diagnostic criteria include corticosteroid responsiveness, but in some cases, they are refractory to corticosteroids. In steroid non-responders, other immunomodulatory therapies could be applied. Recently, Rituximab is reported as a safe and effective treatment for Hashimoto’s encephalopathy. We report a 50-year-old woman with Hashimoto’s encephalopathy presented with confusion and catatonia who was refractory to corticosteroid and immunoglobulin but effectively treated with rituximab.
Abstract
Hashimoto’s encephalopathy is a rare autoimmune disease, with symptoms of encephalopathy and high titers of serum anti-thyroid antibodies. Current diagnostic criteria include corticosteroid responsiveness, but in some cases, they are refractory to corticosteroids. In steroid non-responders, other immunomodulatory therapies could be applied. Recently, Rituximab is reported as a safe and effective treatment for Hashimoto’s encephalopathy. We report a 50-year-old woman with Hashimoto’s encephalopathy presented with confusion and catatonia who was refractory to corticosteroid and immunoglobulin but effectively treated with rituximab.
참고문헌 (10)
- Mocellin R, "Hashimoto's encephalopathy: epidemiology, pathogenesis and management", CNS Drugs, 21, pp.799~811 (2007)[DOI]
- Lee TY, "A case of Hashimoto's encephalopathy", J Korean Neurol Assoc, 18, pp.454~458 (2000)
- Jacob S, "Hashimoto's encephalopathy: steroid resistance and response to intravenous immunoglobulins", J Neurol Neurosurg Psychiatry, 76, pp.455~456 (2005)[DOI]
- Maas A, "Risks and benefits of rituximab in the treatment of Hashimoto encephalopathy in children: two case reports and a Mini Review", Pediatr Neurol, 66, pp.28~31 (2017)[DOI]
- Mijajlovic M, "Clinical manifestations, diagnostic criteria and therapy of Hashimoto's encephalopathy: report of two cases", J Neurol Sci, 288, pp.194~196 (2010)[DOI]
- Singh H, "Spectroscopic correlation and role of Azathioprine in long-term remission in patients of Hashimoto encephalopathy", Ann Indian Acad Neurol, 16, pp.443~446 (2013)[DOI]
- Ochi H, "Proteomic analysis of human brain identifies alpha-enolase as a novel autoantigen in Hashimoto's encephalopathy", FEBS Lett, 528, pp.197~202 (2002)[DOI]
- Olmez I, "Diagnostic and therapeutic aspects of Hashimoto's encephalopathy", J Neurol Sci, 331, pp.67~71 (2013)[DOI]
- Cohen MD, "Rituximab for rheumatoid arthritis", Rheumatol Ther, 2, pp.99~111 (2015)[DOI]
- Lee WJ, "Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort", Neurology, 86, pp.1683~1691 (2016)[DOI]